Epicutaneous Immunotherapy (EPIT®)
DBV’ therapeutic approach is based on epicutaneous immunotherapy (EPIT®), a method of delivering allergen through the skin to induce desensitization in allergic patients.
Viaskin® Technology Electrospray
This process sprays a liquid solution of electrically charged proteins onto the patch’s backing, which is then turned into a dry solid charged particle, which remains stuck onto the patch’s backing.
Viaskin® Technology Manufacturing
Over the past five years, DBV Technologies has tailored an electrospray technology to conduct further clinical development of Viaskin® technologyand for its subsequent commercialization.